Genomed Spólka Akcyjna (WSE:GEN)
Poland flag Poland · Delayed Price · Currency is PLN
24.00
-2.00 (-7.69%)
At close: May 20, 2026

Genomed Spólka Akcyjna Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
29.5829.1223.0122.4820.4619.89
Revenue Growth (YoY)
21.90%26.58%2.34%9.88%2.84%6.08%
Cost of Revenue
10.069.88.518.378.287.34
Gross Profit
19.5219.3314.4914.1112.1812.55
Selling, General & Admin
14.0813.6511.8911.4810.4210.11
Other Operating Expenses
0.780.80.660.760.670.34
Operating Expenses
15.6615.2113.2912.8611.8211.21
Operating Income
3.864.121.21.240.361.34
Interest Expense
-0-0-0-0-0-0
Interest & Investment Income
0.040.03000-
Other Non Operating Income (Expenses)
-0.15-0.110.01-0.190.01-0
EBT Excluding Unusual Items
3.754.041.211.050.371.33
Gain (Loss) on Sale of Assets
0.090.09----
Pretax Income
3.844.131.211.050.371.33
Income Tax Expense
0.760.770.110.130.030.09
Net Income
3.073.361.110.930.341.24
Net Income to Common
3.073.361.110.930.341.24
Net Income Growth
56.81%203.87%19.32%174.07%-72.70%200.29%
Shares Outstanding (Basic)
-11111
Shares Outstanding (Diluted)
-11111
EPS (Basic)
-2.540.840.700.260.94
EPS (Diluted)
-2.540.840.700.260.94
EPS Growth
-203.87%19.32%174.07%-72.70%200.29%
Free Cash Flow
1.861.98-0.031.76-0.61.7
Free Cash Flow Per Share
-1.50-0.021.33-0.461.28
Gross Margin
65.99%66.36%63.00%62.75%59.52%63.09%
Operating Margin
13.05%14.15%5.23%5.53%1.74%6.72%
Profit Margin
10.38%11.53%4.80%4.12%1.65%6.22%
Free Cash Flow Margin
6.28%6.80%-0.12%7.84%-2.94%8.52%
EBITDA
4.664.881.931.861.082.1
EBITDA Margin
15.74%16.75%8.38%8.28%5.27%10.57%
D&A For EBITDA
0.80.760.720.620.720.77
EBIT
3.864.121.21.240.361.34
EBIT Margin
13.05%14.15%5.23%5.53%1.74%6.72%
Effective Tax Rate
19.92%18.66%8.89%11.94%8.39%7.11%
Revenue as Reported
29.5829.1223.0122.4820.4619.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.